Literature DB >> 18468545

Stroke.

Geoffrey A Donnan1, Marc Fisher, Malcolm Macleod, Stephen M Davis.   

Abstract

Stroke is the second most common cause of death and major cause of disability worldwide. Because of the ageing population, the burden will increase greatly during the next 20 years, especially in developing countries. Advances have occurred in the prevention and treatment of stroke during the past decade. For patients with acute stroke, management in a stroke care unit, intravenous tissue plasminogen activator within 3 h or aspirin within 48 h of stroke onset, and decompressive surgery for supratentorial malignant hemispheric cerebral infarction are interventions of proven benefit; several other interventions are being assessed. Proven secondary prevention strategies are warfarin for patients with atrial fibrillation, endarterectomy for symptomatic carotid stenosis, antiplatelet agents, and cholesterol reduction. The most important intervention is the management of patients in stroke care units because these provide a framework within which further study might be undertaken. These advances have exposed a worldwide shortage of stroke health-care workers, especially in developing countries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468545     DOI: 10.1016/S0140-6736(08)60694-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  755 in total

1.  Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7.

Authors:  Naoki Matsumoto; Eriko Suzuki; Makoto Ishikawa; Takumi Shirafuji; Keiji Hasumi
Journal:  J Biol Chem       Date:  2014-10-31       Impact factor: 5.157

2.  Guanosine Protects Against Cortical Focal Ischemia. Involvement of Inflammatory Response.

Authors:  Gisele Hansel; André Comiran Tonon; Felipe Lhywinskh Guella; Letícia Ferreira Pettenuzzo; Thiago Duarte; Marta Maria Medeiros Frescura Duarte; Jean Pierre Oses; Matilde Achaval; Diogo Onofre Souza
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

3.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

4.  C-Reactive Protein Gene Contributes to the Genetic Susceptibility of Hemorrhagic Stroke in Men: a Case-Control Study in Chinese Han Population.

Authors:  Yong Xue; Long Zhang; Yao Fan; Qianhui Li; Yuzhang Jiang; Chong Shen
Journal:  J Mol Neurosci       Date:  2017-07-18       Impact factor: 3.444

5.  Colour Doppler Evaluation of Extracranial Carotid Artery in Patients Presenting with Acute Ischemic Stroke and Correlation with Various Risk Factors.

Authors:  Samrin Haq; Manoj Mathur; Jasvir Singh; Navkiran Kaur; Raminderpal Singh Sibia; Rajesh Badhan
Journal:  J Clin Diagn Res       Date:  2017-03-01

6.  Granulocyte-colony-stimulating Factor for Acute Ischemic Stroke: A Randomized Controlled Trial (STEMTHER).

Authors:  Andrey Marisovich Alasheev; Andrey Avgustovich Belkin; Ilya Naumovich Leiderman; Roman Alekseyevich Ivanov; Tatyana Mikhailovna Isakova
Journal:  Transl Stroke Res       Date:  2011-08-04       Impact factor: 6.829

Review 7.  Neuroinflammatory basis of metabolic syndrome.

Authors:  Sudarshana Purkayastha; Dongsheng Cai
Journal:  Mol Metab       Date:  2013-10-05       Impact factor: 7.422

8.  Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study.

Authors:  Joseph J Keller; Jung-Lung Hsu; Shiue-Ming Lin; Chia-Chi Chou; Li-Hsuan Wang; Jui Wang; Chyi-Huey Bai; Hung-Yi Chiou
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

Review 9.  Does Na⁺/Ca²⁺ exchanger, NCX, represent a new druggable target in stroke intervention?

Authors:  Giuseppe Pignataro; Rossana Sirabella; Serenella Anzilotti; Gianfranco Di Renzo; Lucio Annunziato
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

10.  Effective neuroprotection by ischemic postconditioning is associated with a decreased expression of RGMa and inflammation mediators in ischemic rats.

Authors:  Yuhan Kong; Mary R Rogers; Xinyue Qin
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.